Christos Ierna is an associate in the Paris office of Latham & Watkins. He primarily advises clients on corporate law, mergers and acquisitions, and private equity.

Mr. Ierna's experience includes advising:

  • General Catalyst on the €385 million Series A financing round of Mistral AI, a French start-up specializing in generative artificial intelligence
  • Inari Medical in its acquisition of LimFlow
  • ArchiMed Portfolio Company, Natus Medical Incorporated, in its acquisition of Micromed, a global provider of neurophysiology solutions
  • Astorg Partners in its the binding agreement to acquisition ofre CordenPharma, a leading pharmaceutical contract development and manufacturing organization, from International Chemical Investors Group (ICIG)
  • TA Associates in its acquisition of a majority growth investment in DL Software 
  • Ardian in:
    • its acquisition of a majority stake in Inula Group, a France-based company that the develops, produces, and distributes phytotherapeutic remedies 
    • the sale of the Kersia group (global leader in biosecurity and food safety), other co-investors, and managers to IK Investment Partners 
  • Atomico in its investment in Sorare’s Series B raise, the largest ever in the non-fungible token (NFT) space
  • Körber, an international technology company, in the sale of a minority stake in its supply chain software business to KKR 
  • SHD in the acquisition of a majority stake in Pragma Informatique 

Bar Qualification

  • Avocat (Paris)
  • New York


  • Master of Laws (LL.M.), University of Pennsylvania Law School, 2017
  • Postgraduate Degree Finance, Sciences Po Paris, 2017
  • Business and Law Certificate, Wharton School, University of Pennsylvania, 2017
  • Diploma in Law, University of Oxford, 2014
  • Master of Law, Université Paris II, Panthéon-Assas, 2014

Languages Spoken

  • English
  • French
  • Greek
  • Italian